News
The countries racing to order COVID-19 antiviral pill
Countries right around the world are rushing to place orders for a new Covid-19 antiviral pill, despite the drug not yet receiving authorisation for use
The desire to get in early has been sparked by many poorer nations throughout Asia slow-off the mark to secure vaccines, with leaders not wanting to make the same mistake again.
The new drug is produced by US pharmaceutical giant Merck and is being called a potential pandemic game changer.
The company is seeking emergency authorisation from America’s Food and Drug Administration.
The approval would mean that this is the first-ever oral antiviral treatment against Covid-19.
At least eight countries throughout the Asia-Pacific region have signed deals or have begun talks with the company including New Zealand, Australia and South Korea.
The treatment works once a patient is diagnosed with Covid-19… whereby they start a course of the drug over five days.
News
Tech stocks on edge ahead of Nvidia
Nvidia’s earnings report could impact tech sector trends, prompting analysis of profit-taking versus deeper market concerns.
Nvidia’s earnings report could impact tech sector trends, prompting analysis of profit-taking versus deeper market concerns.
With Nvidia’s crucial earnings on deck, expectations are sky-high and the outcome could set the tone for the entire tech sector.
Chris Weston from Pepperstone breaks down whether this rotation signals simple profit-taking or deeper market concerns.
#TechStocks #Nvidia #Markets #Investing #FinanceNews
News
U.S. House forces release of Epstein files after Trump shift
House votes to release Epstein files after Trump’s stance shift, as victims rally and Senate vote approaches. #EpsteinFiles
House votes to release Epstein files after Trump’s stance shift, as victims rally and Senate vote approaches. #EpsteinFiles
The U.S. House has overwhelmingly voted to mandate the release of Justice Department files tied to Jeffrey Epstein, following a sudden shift in stance from President Donald Trump.
Victims rallied outside the Capitol as bipartisan criticism intensifies and the resolution heads to a swift Senate vote.
#EpsteinFiles #USPolitics #BreakingNews #Congress #Trump
News
Trump’s approval rating hits lowest point amid concerns
Trump’s approval plummets to 38% amid cost of living concerns and Epstein files backlash
Trump’s approval plummets to 38% amid cost of living concerns and Epstein files backlash
– Trump’s approval rating has dropped to 38% due to concerns over costs and the Epstein investigation.
– Only 26% of Americans approve of Trump’s handling of everyday expenses amidst rising inflation.
Poll findings show Trump’s overall approval has declined two points since early November. He began his second term with a 47% approval rating, now nearing lows seen during his first term. Biden’s approval fell as low as 35%, reflective of economic discontent.
Republican Support Wanes
Trump’s approval rating among Republican voters is now 82%, a decrease from 87% earlier this month. The perception that he is not adequately addressing living costs is a significant concern, contributing to reduced popularity among constituents. Notably, only 20% approve of Trump’s handling of the Epstein case, with 70% believing the government is withholding information.
Trump’s economic strategy, which included tax increases on imports, has been criticized for contributing to rising prices. As midterm elections approach, his declining popularity may pose challenges for Republican candidates in upcoming races.
-
Shows2 days agoKnowing when to walk away in real estate deals
-
News2 days ago
Trump-Xi APEC talks stir Taiwan concerns
-
News2 days ago
Australia’s top-selling ute is finally going electric
-
News2 days ago
Are Australia’s streaming rules going too far?
-
Leaders1 day ago
Wealth building requires discipline over chasing returns
-
News1 day ago
U.S. shutdown ends: what’s next?
-
News1 day ago
Trump Threatens $5B BBC Lawsuit
-
News6 hours ago
Microsoft and Nvidia invest heavily in Anthropic
